OECD Harmonised Template 201: Intermediate effects


Non-apical observations during in vitro testing, i.e. intermediate effects on molecular, subcellular, cell, tissue or organ level that can be relevant to the hazard assessment (and possibly inform the adverse outcome pathways). 

No.TemplateLast updatePredefined tables
& Executive summaries
OECD Test Guideline(s)
201 Intermediate effects * April 2016 none none

* New template as from April 2016.

All XML Schema (in one zip file)